The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Novartis; Roche
Travel, Accommodations, Expenses - MSD; Novartis; Roche
Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
 
Jessica Cecile Hassel
Honoraria - BMS, MSD, Roche, GSK/Novartis, Amgen
Consulting or Advisory Role - MSD, Amgen
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - BMS, MSD, Amgen, GSK
 
Andrea Forschner
No Relationships to Disclose
 
Leonie Blum
Honoraria - Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Lucie Heinzerling
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck; MSD; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck; MSD; Roche
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Lisa Zimmer
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
 
Jochen Utikal
Honoraria - Amgen; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - GlaxoSmithKline; MSD; Novartis; Roche
Speakers' Bureau - GlaxoSmithKline; MSD; Novartis; Roche
Research Funding - BioNTech (Inst); Rheacell (Inst); TILT Biotherapeutics (Inst)
Travel, Accommodations, Expenses - Amgen; GlaxoSmithKline; MSD; Novartis; Roche
 
Katharina C. Kähler
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Roche
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
 
Max Schlaak
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Carmen Loquai
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
 
Ralf Gutzmer
Honoraria - Almirall Hermal GmbH; Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD; Novartis; Roche
Consulting or Advisory Role - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; LEO Pharma; MSD; Novartis; Pfizer; Roche
Research Funding - Johnson & Johnson (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Felix Kiecker
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
 
Carola Berking
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck Sharp & Dohme; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Roche
 
Armin Bender
Consulting or Advisory Role - Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis
 
Lars Schneider
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Roche
 
Alexander Enk
Honoraria - Abbvie; Biotest; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Biofrontera; Biotest; Bristol-Myers Squibb; Galderma; MSD
Travel, Accommodations, Expenses - Abbvie; Biotest; Bristol-Myers Squibb; MSD
 
Claus Garbe
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Michael Weichenthal
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche; Teva
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche; Takeda; Teva
Research Funding - Millennium (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD
 
Dirk Schadendorf
Honoraria - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Grunenthal; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech; Sysmex
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Grunenthal; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech; Sysmex
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche/Genentech
 
Axel Hauschild
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
 
Peter Mohr
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche